Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader application in neurodegenerative diseases. Researchers have developed promising new therapies that selectively target and destroy aggregated tau proteins, which are associated with Alzheimer’s disease, and improve symptoms of neurodegeneration in mice. According to the researchers, this approach could also be […]
Source link
